Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals (TSE:CPH) and Canopy Growth (TSE:WEED) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.

Does the MarketBeat Community believe in CPH or WEED?

Canopy Growth received 462 more outperform votes than Cipher Pharmaceuticals when rated by MarketBeat users. However, 62.46% of users gave Cipher Pharmaceuticals an outperform vote while only 62.20% of users gave Canopy Growth an outperform vote.

Company	Underperform	Outperform
Cipher Pharmaceuticals	Outperform Votes 178 62.46%	Underperform Votes 107 37.54%
Canopy Growth	Outperform Votes 640 62.20%	Underperform Votes 389 37.80%

Which has more volatility & risk, CPH or WEED?

Cipher Pharmaceuticals has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500.

Which has preferable earnings & valuation, CPH or WEED?

Cipher Pharmaceuticals has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cipher Pharmaceuticals	C$22.14M	9.45	C$22.68M	C$1.23	7.06
Canopy Growth	C$362.24M	2.09	-C$1.18B	-C$21.30	-0.47

Do institutionals and insiders hold more shares of CPH or WEED?

1.1% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 14.0% of Canopy Growth shares are held by institutional investors. 44.5% of Cipher Pharmaceuticals shares are held by insiders. Comparatively, 0.3% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media refer more to CPH or WEED?

In the previous week, Canopy Growth had 5 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 5 mentions for Canopy Growth and 0 mentions for Cipher Pharmaceuticals. Canopy Growth's average media sentiment score of 1.02 beat Cipher Pharmaceuticals' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Overall Sentiment
Cipher Pharmaceuticals	Neutral
Canopy Growth	Positive

Is CPH or WEED more profitable?

Cipher Pharmaceuticals has a net margin of 102.43% compared to Canopy Growth's net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 29.70% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cipher Pharmaceuticals	102.43%	29.70%	8.09%
Canopy Growth	N/A	-121.56%	-8.89%

Do analysts rate CPH or WEED?

Cipher Pharmaceuticals currently has a consensus target price of C$8.75, suggesting a potential upside of 1.16%. Canopy Growth has a consensus target price of C$6.88, suggesting a potential downside of 31.86%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe Cipher Pharmaceuticals is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Summary

Cipher Pharmaceuticals beats Canopy Growth on 12 of the 18 factors compared between the two stocks.